ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselCanVirex AG
CanVirex AG Logo
Verified· 2 sources

CanVirex AG

Summary

About the company

The core activity of CanVirex AG is the development and research in the field of immunooncology and vaccination, particularly in biotechnology and pharmaceuticals. The company focuses on the development of viral vectors and immunotherapeutics.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered3
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Oncolytic Immunotherapy (Measles Vector Platform)
Oncolytic measles vectors for cancer immunotherapy, with selective tumor-cell lysis, immune-modulating transgenes and patient-specific immune activation against solid tumors.
Vector-based Vaccine Development
Measles vector platform for delivering pathogen-specific antigens for vaccination against infectious diseases, including SARS-CoV-2 antigens and cellular and humoral immune responses.
Biomarker and Translational Program
Supportive translational program with testing of molecular signatures and predictive biomarkers for patient-specific selection in future clinical trials.
Comparisons

CanVirex AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank CanVirex AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of CanVirex AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Malzgasse 9
4052 Basel

At a glance

Legal form
Corporation
UID
CHE-228.978.735
Founded
2017 · 9 years
Last commercial register change
June 18, 2026
Employees
11 to 20

Knowledge

No knowledge articles yet

Once CanVirex AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

RA
Rocketvax AG
Basel
AS
Azafaros Switzerland AG
Basel
TP
Torpedo Pharmaceuticals AG
Basel
RA
Rhenochem AG
Basel
LG
Lonza Group AG
Basel
FA
FimmCyte AG
Basel
NA
NOUSCOM AG
Basel
FI
FatiAbGen International GmbH
Basel